AI/ML-enabled medical device firms paid $39.7 million for radiology devices from 2017–2023, raising transparency concerns.
Key Details
- 1AI/ML-enabled medical device developers paid $39.7M for radiology devices over seven years.
- 2Total industry payments to healthcare entities reached $179M in the same period; only cardiovascular devices saw more ($59.4M).
- 3Researchers identified 846 FDA-listed AI/ML-enabled medical devices, but only 79 (9.3%) disclosed payment data.
- 4Annual payments rose from $17.3M in 2017 to $24.6M in 2023, with general payments doubling from $6.6M to $13.3M.
- 5The number of physician and hospital payment recipients more than doubled, but most manufacturers reported no payments.
- 6Study suggests underreporting may occur due to differing device clearance, reimbursement, and classification pathways.
Why It Matters
Financial incentives from AI device manufacturers may influence adoption and promotion decisions in radiology, underlining the importance of transparency. Calls for modernized disclosure requirements could affect radiology-AI industry practices and regulatory oversight.
Source
AuntMinnie
Related News
•AuntMinnie
Study: Patients Prefer AI in Radiology as Assistive, Not Standalone Tool
Survey finds patients support AI-assisted radiology but not AI-only interpretations.
•AuntMinnie
AI-Enhanced MRI Boosts Return-to-Play Predictions for Athlete Muscle Injuries
Adding AI to MRI-based classification systems improves return-to-play predictions for professional athletes with muscle injuries.
•Radiology Business
Workflow Efficiency Tops AI ROI in Radiology Practices
Survey finds that AI's main ROI for radiology practices is improved workflow efficiency rather than direct financial gains.